Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Under Pressure, CMS Backs Off New Part D Protected Class Management

May 17 2019

• By Cathy Kelly

RollOfDollarswithPills_1200x675 — CMS Final Rule On Part D Protected Class Drugs A Win For Manufacturers

Related Content

Humana Jumps In: Medicare Part B Step Therapy Program Includes Cancer Drugs

Jan 30 2019

Narrowing Part D Protected Classes Won’t Be Proposed Again – Tavenner

Sep 26 2014

Part D Protected Class Management Tools To Save Medicare $1.85bn

Nov 27 2018

Additional Topics

United States Regulation Reimbursement Pricing Debate BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.